Sign In
Buy ACAD
$22.60
+0.510 (+2.31%)
At Close: Jun 23, 2026
ACADIA Pharmaceuticals (ACAD) CEO Stephen Davis on Q3 2021 Results - Earnings Call Transcript
11:38pm, Monday, 08'th Nov 2021
ACADIA Pharmaceuticals (ACAD) CEO Stephen Davis on Q3 2021 Results - Earnings Call Transcript
Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Tops Revenue Estimates
07:09pm, Monday, 08'th Nov 2021
Acadia (ACAD) delivered earnings and revenue surprises of 66.67% and 3.32%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
4 Healthcare Stocks to Top Q3 Estimates Amid Coronavirus Woes
11:51am, Tuesday, 26'th Oct 2021
Factors like an aging populace and demand for products and services are likely to reflect on the Q3 results of ACAD, MD, ACHC and VRTX.
Neurocrine, ACADIA: Fast Growing Health Care Stocks That Are Underperforming
09:00am, Tuesday, 26'th Oct 2021
Our theme of Out Of Favor Health Care Stocks includes biotech and pharma names that are seeing a disconnect between their recent financial performance and recent stock price returns. The theme remains
3 Biotech Stocks to Watch Now
11:07am, Tuesday, 12'th Oct 2021
Biotech companies develop new medicines, vaccines, or medical devices. They use advanced technologies and medical science to do so.
Can These Former Biotech Growth Stocks Regain Their Form?
10:00am, Wednesday, 29'th Sep 2021
Acadia Pharmaceuticals and Clovis Oncology may be turnaround stories in the making.
Acadia Pharmaceuticals: Refunding A Former Champion
05:53am, Wednesday, 29'th Sep 2021
Acadia Pharmaceuticals: Refunding A Former Champion
How Does Acadia Stock Performance In The Current Crisis Compare With That In 2008?
07:45am, Wednesday, 08'th Sep 2021
We believe that Acadia Pharmaceuticals stock, a biopharmaceutical company focused on neuroscience drugs, is a good buying opportunity at the present time. ACAD stock trades around $17 levels currently
Acadia Pharmaceuticals Announces Executive Leadership Change
04:05pm, Wednesday, 01'st Sep 2021
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Elena Ridloff, Executive Vice President and Chief Financial Officer (CFO), will be leaving the company effec
Why Acadia Healthcare (ACHC) Stock Might be a Great Pick
10:49am, Wednesday, 25'th Aug 2021
Acadia Healthcare (ACHC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
ACADIA (ACAD) Q2 Earnings Beat, Revenues Miss Estimates
02:28pm, Thursday, 05'th Aug 2021
ACADIA's (ACAD) loss narrows in the second quarter of 2021 while its revenues miss the mark. The company has reduced its revenue guidance for 2021.
4 Bullish Stock Picks After Earnings With Huge Potential Upside
11:12am, Thursday, 05'th Aug 2021
Earnings season is winding down. With that come analyst projections for where these stocks and the market in general could go in the coming months.
ACADIA Pharmaceuticals, Inc. (ACAD) CEO Stephen Davis on Q2 2021 Results - Earnings Call Transcript
12:13am, Thursday, 05'th Aug 2021
ACADIA Pharmaceuticals, Inc. (ACAD) CEO Stephen Davis on Q2 2021 Results - Earnings Call Transcript
Acadia Pharmaceuticals (ACAD) Reports Q2 Loss, Misses Revenue Estimates
07:04pm, Wednesday, 04'th Aug 2021
Acadia (ACAD) delivered earnings and revenue surprises of 10.00% and -9.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Acadia Healthcare's (ACHC) Solid Results Lead to Stock Rally
03:15pm, Wednesday, 04'th Aug 2021
Acadia Healthcare Company (ACHC) gains from rising demand for its behavioral healthcare services and investors' optimism on clarity about its growth strategies.
